Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockade

Jiao Liu; Rui Kang; Guido Kroemer; Daolin Tang

doi:10.1080/2162402X.2022.2068488

Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockade

Jiao Liu, Rui Kang, Guido Kroemer, Daolin Tang

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Interferon gamma (IFNG/IFNγ)-induced adaptive immune resistance remains a challenge for tumor therapy. We observed that the chaperone heat shock protein 90 (HSP90) stabilizes the transcription factor signal transducer and activator of transcription 1 (STAT1), resulting in IFNγ-induced expression of immunosuppressive indoleamine 2,3-dioxygenase 1 (IDO1) and programmed death-ligand 1 (PD-L1/CD274). Pharmacological inhibition of HSP90 enhances the efficacy of programmed cell death 1 (PDCD1/PD-1) targeting immunotherapy in suitable mouse models without any toxicity.

Original language	English (US)
Article number	2068488
Journal	OncoImmunology
Volume	11
Issue number	1
DOIs	https://doi.org/10.1080/2162402X.2022.2068488
State	Published - 2022

Keywords

Adaptive immune resistance
immune checkpoint
molecular chaperone
pancreatic cancer
protein degradation

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Oncology

Access to Document

10.1080/2162402X.2022.2068488

Cite this

@article{a68e1b529fca4e5ebdf6762418433881,

title = "Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockade",

abstract = "Interferon gamma (IFNG/IFNγ)-induced adaptive immune resistance remains a challenge for tumor therapy. We observed that the chaperone heat shock protein 90 (HSP90) stabilizes the transcription factor signal transducer and activator of transcription 1 (STAT1), resulting in IFNγ-induced expression of immunosuppressive indoleamine 2,3-dioxygenase 1 (IDO1) and programmed death-ligand 1 (PD-L1/CD274). Pharmacological inhibition of HSP90 enhances the efficacy of programmed cell death 1 (PDCD1/PD-1) targeting immunotherapy in suitable mouse models without any toxicity.",

keywords = "Adaptive immune resistance, immune checkpoint, molecular chaperone, pancreatic cancer, protein degradation",

author = "Jiao Liu and Rui Kang and Guido Kroemer and Daolin Tang",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.",

year = "2022",

doi = "10.1080/2162402X.2022.2068488",

language = "English (US)",

volume = "11",

journal = "OncoImmunology",

issn = "2162-4011",

publisher = "Landes Bioscience",

number = "1",

}

TY - JOUR

T1 - Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockade

AU - Liu, Jiao

AU - Kang, Rui

AU - Kroemer, Guido

AU - Tang, Daolin

PY - 2022

Y1 - 2022

N2 - Interferon gamma (IFNG/IFNγ)-induced adaptive immune resistance remains a challenge for tumor therapy. We observed that the chaperone heat shock protein 90 (HSP90) stabilizes the transcription factor signal transducer and activator of transcription 1 (STAT1), resulting in IFNγ-induced expression of immunosuppressive indoleamine 2,3-dioxygenase 1 (IDO1) and programmed death-ligand 1 (PD-L1/CD274). Pharmacological inhibition of HSP90 enhances the efficacy of programmed cell death 1 (PDCD1/PD-1) targeting immunotherapy in suitable mouse models without any toxicity.

AB - Interferon gamma (IFNG/IFNγ)-induced adaptive immune resistance remains a challenge for tumor therapy. We observed that the chaperone heat shock protein 90 (HSP90) stabilizes the transcription factor signal transducer and activator of transcription 1 (STAT1), resulting in IFNγ-induced expression of immunosuppressive indoleamine 2,3-dioxygenase 1 (IDO1) and programmed death-ligand 1 (PD-L1/CD274). Pharmacological inhibition of HSP90 enhances the efficacy of programmed cell death 1 (PDCD1/PD-1) targeting immunotherapy in suitable mouse models without any toxicity.

KW - Adaptive immune resistance

KW - immune checkpoint

KW - molecular chaperone

KW - pancreatic cancer

KW - protein degradation

UR - http://www.scopus.com/inward/record.url?scp=85128857794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85128857794&partnerID=8YFLogxK

U2 - 10.1080/2162402X.2022.2068488

DO - 10.1080/2162402X.2022.2068488

M3 - Article

C2 - 35496499

AN - SCOPUS:85128857794

SN - 2162-4011

VL - 11

JO - OncoImmunology

JF - OncoImmunology

IS - 1

M1 - 2068488

ER -

Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockade

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this